This is the first randomized controlled trial investigating the efficacy and safety of low-dose prolonged methylprednisolone administration in early ARDS. This study tested a pathophysiologic ...

Methods: We used the Medline database to select studies with the key words “acute lung injury,” “ARDS,” “acute respiratory ... Importantly, ARDS is a syndrome and not an illness, and ...

The Extracorporeal Life Support Organization has documented the application of venovenous extracorporeal membrane oxygenation ...

Acute respiratory-distress syndrome (ARDS) affects around 10% of people in intensive-care units (ICUs) and occurs in all age groups from newborns to the elderly. It can develop following bacterial ...

Patients with acute respiratory distress syndrome faced an accelerated and ... 1,236 pediatric patients (median age, 4 years) with ARDS from two observational cohorts, 1,079 adults (median age ...

CK-0802 is under clinical development by Cellenkos and currently in Phase I for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome.

Sepsis, a severe and often fatal complication of infection, is a leading cause of both ALI and acute respiratory distress ...

Healios KK (JP:4593) has released an update. Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

Ibudilast is under clinical development by MediciNova and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome.